24-04-09	Affärsvärlden maintains its buy recommendation for Slottsviken after property acquisition	FW
23-09-27	Affärsvärlden maintains its buy recommendation for Slottsviken	FW
23-08-30	Affärsvärlden suggests seven interesting real estate shares	FW

More recommendations

Managers and Directors: Conpharm AB

Manager	Title	Age	Since
Jakob Österberg CEO	Chief Executive Officer	47	2012-12-31

Director	Title	Age	Since
Peter Hamnebo CHM	Chairman	49	2012-12-31
Jakob Österberg BRD	Director/Board Member	47	2012-12-31
Fredrik Lars Josef Österberg CHM	Chairman	51	2012-12-31

More insiders

Other Real Estate Development & Operations

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NFINITI INC.	+252.94%	-99.80%	-99.74%	-	95.45B
SUN HUNG KAI PROPERTIES LIMITED	+1.56%	-3.23%	+36.52%	+13.59%	42.6B
CHINA RESOURCES LAND LIMITED	+1.08%	+3.79%	+40.15%	+15.24%	33.56B
MITSUBISHI ESTATE CO., LTD.	+1.60%	+6.74%	+57.74%	+150.21%	31.05B
EMAAR PROPERTIES	+8.33%	+3.36%	-13.01%	+93.39%	25.99B
MITSUI FUDOSAN CO., LTD.	+1.30%	+6.17%	+15.66%	+65.16%	26.04B
CHINA OVERSEAS LAND & INVESTMENT LIMITED	+0.45%	+0.32%	+14.19%	-10.85%	21.81B
CK ASSET HOLDINGS LIMITED	+1.62%	+0.17%	+37.53%	+3.19%	20.34B
SUMITOMO REALTY & DEVELOPMENT CO., LTD.	+2.91%	+1.45%	+25.21%	+95.24%	19.96B
Average	+30.20%	-0.58%	+12.70%	+53.15%	35.2B
Weighted average by Cap.	+77.80%	-0.54%	-10.03%	+52.44%

See all sector performances

Slottsviken Fastighetsaktiebolag (publ), formerly Conpharm AB (publ), is a Sweden-based company involved in real estate sector. The Company owns and manages residential, office and commercial properties in peri-urban locations. Slottsviken Fastighetsaktiebolag (publ) is a real estate company that acquires, manages and develops attractive properties in urban areas with a focus on the Gothenburg region. Its property portfolio includes residential properties; and commercial premises for production, shop/trade, restaurants, industry, workshops, logistics, and offices. The company also invests in securities; and owns and manages intellectual property rights relating to Reumacon and Wartec life science activities.

Employees

Sector

Real Estate Development & Operations

More about the company

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!

Market Cap	53.6M 5.7M 4.93M 4.54M 4.25M 7.96M 542M 8.09M 20.9M 264M 21.41M 20.95M 914M	P/E Ratio 2024	23.1x	P/E Ratio 2025	28.8x
Enterprise Value	105M 11.15M 9.63M 8.87M 8.31M 15.57M 1.06B 15.81M 40.86M 516M 41.85M 40.96M 1.79B	EV / Sales 2024	8.35x	EV / Sales 2025	9.69x
Free-Float	83.79%	Yield 2024	0.3%	Yield 2025	0.3%

05-27	Slottsviken shares trade ex-dividend today on Spotlight at SEK 0.12 per share	FW
05-19	Slottsviken's long-term net asset value edges higher in Q1	FW
04-28	Slottsviken Fastighetsaktiebolag announces Annual dividend, payable on June 02, 2026	CI
02-26	Slottsviken Increases Dividend	FW
02-26	Slottsviken Fastighetsaktiebolag Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-24	Slottsviken Increases Net Asset Value in the Third Quarter	FW
11-21	Slottsviken Fastighetsaktiebolag Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-22	Slottsviken Improves Net Profit in Q2	FW
25-08-21	Slottsviken Fastighetsaktiebolag Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-07-04	Slottsviken Acquires Property in Sävenäs	FW
25-06-03	Slottsviken's major shareholder Daniel Stensiö increases his shareholding	FW
25-06-02	Major shareholder Lackarebäck makes a small share purchase in Slottsviken	FW
25-05-28	Slottsviken reports increased net asset value as a result of higher property values	FW

	2024	2025
Net sales	13.08M 1.39M 1.2M 1.11M 1.04M 1.94M 132M 1.97M 5.1M 64.38M 5.22M 5.11M 223M	13.53M 1.44M 1.24M 1.15M 1.07M 2.01M 137M 2.04M 5.28M 66.63M 5.4M 5.29M 231M
Net income	2.78M 296K 256K 236K 220K 413K 28.13M 420K 1.08M 13.69M 1.11M 1.09M 47.4M	2.78M 296K 256K 236K 221K 413K 28.14M 420K 1.08M 13.7M 1.11M 1.09M 47.42M
Net Debt	41.65M 4.43M 3.83M 3.53M 3.3M 6.19M 421M 6.28M 16.24M 205M 16.63M 16.28M 710M	51.19M 5.45M 4.7M 4.34M 4.06M 7.61M 518M 7.72M 19.96M 252M 20.44M 20.01M 873M

Conpharm AB Stock Swiss Exchange

Stocks

CONP.B

SE0000102840

Real Estate Development & Operations

Valuation: Conpharm AB

Latest news : Conpharm AB

Analysts' recommendations: Conpharm AB

Managers and Directors: Conpharm AB

Other Real Estate Development & Operations

Financials

Company Profile